The Department of Health (DOH) on Friday responded to circulating social media posts claiming a new health crisis in China, reassuring the public that these reports are not backed by reliable sources.
The posts in question have been spreading alarming news about a supposed epidemic in China, allegedly involving rising cases of human metapneumovirus infections, influenza A, and COVID-19, with reports of overwhelmed hospitals and crematories.
However, the DOH clarified, “There is no confirmation from either the cited country or the World Health Organization (WHO).”
The DOH emphasized that the Philippines, as an active member of the WHO, relies on a well-established network for international health updates. This network, guided by the International Health Regulations, ensures that accurate, timely information reaches all member states.
DOH: Monitoring and Verifying
“We are closely monitoring and verifying all relevant health information,” the department assured. “Our disease surveillance systems in the Philippines are fully operational and continue to safeguard the public.”
DOH ADVISORY: January 3, 2025
Related material:
The Philippines is one of 21 countries in the Western Pacific that have conducted a JEE since the process was introduced in 2016. pic.twitter.com/I7jWGpc1rs— Department of Health Philippines (@DOHgovph) January 3, 2025
The DOH also urged the public to be cautious about the sources of health information they share online.
“We encourage everyone to refrain from spreading misinformation and confusion. Only rely on credible websites and official updates,” it said.
Rest assured, the DOH will continue to provide reliable updates as they verify the situation.
Human metapneumovirus (HMPV) is a respiratory virus that belongs to the paramyxovirus family, closely related to other viruses like respiratory syncytial virus (RSV) and parainfluenza. It was first discovered in 2001 and has since been recognized as an important cause of respiratory infections, particularly in children, the elderly, and individuals with weakened immune systems.
Key Facts about HMPV:
- Symptoms: HMPV infections typically cause symptoms similar to those of a common cold or flu. These include coughing, runny nose, fever, and difficulty breathing. In severe cases, it can lead to bronchiolitis or pneumonia, especially in vulnerable populations like infants, the elderly, or those with pre-existing lung conditions.
- Transmission: The virus spreads through respiratory droplets when an infected person coughs or sneezes. A person can contract the virus by touching surfaces contaminated with the virus and then touching the face.
- Seasonality: Like many respiratory viruses, HMPV tends to circulate more during the fall and winter months, although it can cause infections year-round.
- Diagnosis: To diagnose HMPV usually requires laboratory tests such as PCR (polymerase chain reaction) tests, which can detect the viral RNA in respiratory samples.
- Treatment: There is no specific antiviral treatment for HMPV. Treatment generally focuses on alleviating symptoms, such as using fever reducers, staying hydrated, and in more severe cases, providing respiratory support. Most people recover from the infection with supportive care.
- Prevention: Preventive measures include regular handwashing, avoiding close contact with sick individuals, and covering the mouth and nose when coughing or sneezing. There is currently no vaccine available for HMPV, though research is ongoing.
Impact
HMPV is a significant cause of respiratory illness worldwide. It is often underrecognized due to its similarity to other respiratory infections like RSV and influenza. In severe cases, particularly in young children and older adults, it can lead to hospitalization. The virus is typically more problematic for those with existing health conditions or weakened immune systems.
Understanding HMPV and its symptoms can help reduce the impact of potential outbreaks, especially in vulnerable communities.
About The Author
One thought on “DOH Dismisses Misinformation About Alleged Health Crisis in China”